The Primary Aim is to Compare the Outcomes of Autogenous Dentin Graft (ADG) Combined with Either Albumin Platelet-rich Fibrin (ALB-PRF) or Standard Platelet-rich Fibrin (PRF) in Terms of Bone Preservation and Healing in the Alveolar Socket.

Launched by KAFRELSHEIKH UNIVERSITY · Dec 26, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how different treatments can help preserve and heal bone after a tooth is removed. When a tooth is lost, the bone around it can shrink significantly, especially in the first few months. To prevent this, the study will compare two methods using a special type of graft made from the patient's own tooth material, called autogenous dentin, combined with either a standard treatment or a new treatment that uses a healing membrane made from the patient’s blood and albumin. The aim is to see which method better supports bone healing and prepares the area for future dental work.

To participate in this study, patients must be between 18 and 60 years old and need to have a tooth that can’t be saved, specifically in the back of the mouth. They should not have any serious health conditions or habits, like smoking, that could affect healing. Participants can expect to have their tooth extracted and then receive one of the treatments being studied. This trial is not yet open for recruiting, but it aims to improve recovery after tooth extractions and help maintain healthy bone structure for future dental needs.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Medically free patients.
• • Adult patients above 18 Years to 60 Years.
• • Non-restorable tooth indicated for extraction.
• • Posterior mandibular teeth.
• • Inactive infection related to the tooth.
• • Cooperative patients.
• Exclusion Criteria:
• • Presence of any systemic disease that could influence the outcome of the therapy.
• • Presence of any risk factor (smoker, pregnant and lactating patients).
• • Patients with bone diseases.
• • Patients with poor oral hygiene.